Immunotherapy for Peritoneal Metastases from Gastric Cancer: Rationale, Current Practice and Ongoing Trials

Peritoneal metastases from gastric cancer play a key role in the fatal prognosis of the disease. The lack of efficacy of actual therapeutic approaches together with the outcomes achieved with checkpoint inhibitors in gastric cancer compel us to address the current state-of-the-art immunotherapy trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz Hispán, Eva, Pedregal, Manuel, Cristobal, Ion, García-Foncillas, Jesús, Caramés, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539177/
https://www.ncbi.nlm.nih.gov/pubmed/34682772
http://dx.doi.org/10.3390/jcm10204649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539177/
https://www.ncbi.nlm.nih.gov/pubmed/34682772
http://dx.doi.org/10.3390/jcm10204649

Ejemplares similares